About ImmunXperts
ImmunXperts is a company based in Charleroi (Belgium) founded in 2014 was acquired by Nexelis in March 2020. ImmunXperts has raised $1 million across 2 funding rounds from investors including Biowin, Nexelis and Sambrinvest. The company has 22 employees as of December 31, 2022. ImmunXperts offers products and services including Central Laboratories, Genomics, Discovery Sciences, and Biosciences. ImmunXperts operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Charleroi, Belgium
- Employees 22 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Immunxperts
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ImmunXperts
ImmunXperts offers a comprehensive portfolio of products and services, including Central Laboratories, Genomics, Discovery Sciences, and Biosciences.
Provides clinical trial testing and sample management for drug development.
Offers genomic testing to support precision medicine and research.
Delivers protein and antibody discovery for pharmaceutical applications.
Conducts bioanalytical assays for small and large molecules in drug testing.
Funding Insights of ImmunXperts
ImmunXperts has successfully raised a total of $1M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(16 Dec 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Grant - ImmunXperts | Valuation |
investors |
|
| Dec, 2014 | Amount | Seed - ImmunXperts | Valuation |
investors |
Investors in ImmunXperts
ImmunXperts has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Biowin, Nexelis and Sambrinvest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC & PE fund
|
Founded Year | Domain | Location | |
|
Business development services for medical device manufacturing are provided.
|
Founded Year | Domain | Location | |
|
Assay development and bioanalytical services are provided worldwide.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ImmunXperts
Financial Statements - ImmunXperts
Immunxperts Comparisons
Competitors of ImmunXperts
ImmunXperts operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| domain | founded_year | HQ Location |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| domain | founded_year | HQ Location |
Analytical and quality assurance services are provided for diverse industries.
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| domain | founded_year | HQ Location |
Bioanalytical assays for drug development are developed and validated.
|
|
| domain | founded_year | HQ Location |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
Latest news on Immunxperts
Frequently Asked Questions about ImmunXperts
ImmunXperts was founded in 2014.
ImmunXperts is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
ImmunXperts is a funded company, having raised a total of $1M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Dec 16, 2014.
As of Dec 31, 2022, the latest employee count at ImmunXperts is 22.
ImmunXperts is a CRO engaged in the development of bioassays which involve the human immune system for drug development (biopharmaceutical, biosimilar and vaccines) applications. Their applications include immunogenicity of biotherapeutics (in vitro, in silico, in vivo and clinical services and regulatory support), and immuno-oncology (MLR Assays, Antigen-specific T cell activation and macrophage polarisation assays) and cell therapy (custom assays) development. They also offer services for the development of functional potency assays in the field of stem cell therapy. The company has received 1.6 million euro grant, along with other institutes and companies, to identify innovative drug candidates and biomarkers for immunotherapy of various types of cancer.
ImmunXperts's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
ImmunXperts offers Central Laboratories, Genomics, Discovery Sciences, and Biosciences.
ImmunXperts has 3 investors. Key investors include Biowin, Nexelis, and Sambrinvest.